THE DEAL, AT A GLANCE
From the announcementRemedium Bio
01Who is involvedBacked by Valuence Ventures, Eisai Innovation, SBI US Gateway Fund, other early investorsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedRemedium Bio raised $3.7M Pre-Series A, announced 2026-08-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersRemedium Bio's $3.7M Pre-Series A is a small-capital formation signal within an active Healthcare & Life Sciences funding tape, where 35 other trailing 30-day rounds…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Remedium Bio · Financing Record
Explore source-linked visual explanations for Remedium Bio. Unsupported claims are withheld while source review continues.
Record 9974 · Recorded date: 2026-08-10
Explore company records →